New study to test long-term effects of weight loss drugs
Ozempic, Wegovy, Mounjaro — three new medications used to treat obesity — seemed to be all over the news and social media in 2023. You’ve likely seen or read about their effectiveness, their side effects, their cost and what happens when you quit taking them. But as we grapple with the increasing epidemic of obesity an d its complementary health issues, researchers at Wake Forest University School of Medicine are looking to an older, generic drug for answers.
First approved by the Food and…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Atrium Health Wake Forest Baptist Source Type: news
More News: Biotechnology | Eating Disorders & Weight Management | Epidemics | Epidemiology | Health Management | Obesity | Study | Weight Loss